Aprea Therapeutics - 53 Year Dividend History | APRE
Historical dividend payout and yield for Aprea Therapeutics (APRE) since 1971. The current TTM dividend payout for Aprea Therapeutics (APRE) as of December 20, 2024 is $0.00. The current dividend yield for Aprea Therapeutics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.017B |
$0.001B |
|
Aprea Therapeutics Inc. is a biopharmaceutical company. It is focused on developing and commercializing novel cancer therapeutics which reactivate the mutant tumor suppressor protein, p53. The Company's lead drug candidate, APR-246, a first-in-class small molecule p53 reactivator, is in clinical development for myelodysplastic syndromes, acute myeloid leukemia as well as additional hematologic and solid tumor malignancies. Aprea Therapeutics Inc. is based in Boston, Massachusetts.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
